Angiotensin II Antagonists In Paroxysmal Atrial Fibrillation, Results From The ANTIPAF Trial

Links shared publicly online about this topic.

  • 905
    total visits

Angiotensin II Antagonists In Paroxysmal Atrial Fibrillation, Results From The ANTIPAF Trial

medicalnewstoday.com —

Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting about 7 million people in Europe. It is a progressive chronic disease in which episodes become more frequent and long-last

View full resource at medicalnewstoday.com

Tags: Heart, Heart Disease, Arrhythmia, Atrial Fibrillation, Disease and Condition, disease

  • Share

Most Recently Shared on September 1, 2010 at 7:00 pm By:

mnt_cardiovasc MNT Cardiovascular

Angiotensin II Antagonists In Paroxysmal Atrial Fibrillation, Results From The ANTIPAF Trial http://mnt.to/3J6k #cardiovascular

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

Hisham Rana, MD Hisham Rana, MD

MNT Heart News MNT Heart News

Advertisement